Consultation on Possible Changes to the Food and Drug Regulations: Generic Drug Equivalence and Related Terminology

This consultation document is intended to solicit stakeholder feedback on the proposal and to consider possible impacts on drug development, drug accessibility and interchangeability practices.

How to Get Involved

This consultation is open for comment starting June 30, 2017 until October 27, 2017. Please select and read through the link below titled “consultation document”. Once read please submit your comments via email, fax or by mail to:

policy_bureau_enquiries@hc-sc.gc.ca

Health Canada
Health Products and Food Branch, Therapeutic Products Directorate
Bureau of Policy, Science and International Programs
Address Locator 3102C1
Holland Cross, Tower B
1600 Scott St.
Ottawa, Ontario
K1A 0K9

Telephone: 613-948-4623
Fax number: 613-941-1812

Consultation Document

Interested parties are encouraged to provide comments and suggestions by October 27, 2017.

Reporting to Canadians

If you have any questions, contact us at the Bureau of Policy, Science and International Programs.

Interested in our other consultations? Sign up and stay informed about topics that matter to you.

Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: